Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) 3-Year RORE % : 7.50% (As of Dec. 2025)


STU:JIL Jilin Province Huinan Changlong Bio-pharmacy Co Ltd STU:JIL
81 GF Score
Price €0.25
GF Value €0.18
! 1 Warning Sign
View Full Analysis

What is Jilin Province Huinan Changlong Bio-pharmacy Co 3-Year RORE %?

Jilin Province Huinan Changlong Bio-pharmacy Co STU:JIL 81 3-Year RORE % is 7.50 as of Dec. 2025. GuruFocus rates STU:JIL with a GF Score™ of 81/100 and a GF Value™ of €0.18. The stock has 1 warning sign investors should review. Among 934 Drug Manufacturers companies, Jilin Province Huinan Changlong Bio-pharmacy Co ranks better than 58.57% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Jilin Province Huinan Changlong Bio-pharmacy Co's 3-Year RORE % for the quarter that ended in Dec. 2025 was 7.50%.

The industry rank for Jilin Province Huinan Changlong Bio-pharmacy Co's 3-Year RORE % or its related term are showing as below:

STU:JIL's 3-Year RORE % is ranked better than
58.57% of 934 companies
in the Drug Manufacturers industry
Industry Median: 3.09 vs STU:JIL: 7.50

Jilin Province Huinan Changlong Bio-pharmacy Co  (STU:JIL) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Jilin Province Huinan Changlong Bio-pharmacy Co 3-Year RORE % Related Terms


Jilin Province Huinan Changlong Bio-pharmacy Co 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Jilin Province Huinan Changlong Bio-pharmacy Co's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jilin Province Huinan Changlong Bio-pharmacy Co 3-Year RORE % Chart

Jilin Province Huinan Changlong Bio-pharmacy Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.04 16.36 0.00 -3.23 7.50

Jilin Province Huinan Changlong Bio-pharmacy Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -2.34 -3.23 -4.72 7.50

STU:JIL vs ZTS, UTHR: 3-Year RORE % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jilin Province Huinan Changlong Bio-pharmacy Co's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jilin Province Huinan Changlong Bio-pharmacy Co 3-Year RORE % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jilin Province Huinan Changlong Bio-pharmacy Co's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Jilin Province Huinan Changlong Bio-pharmacy Co's 3-Year RORE % falls into.


STU:JIL
81GF Score
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd STU:JIL
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jilin Province Huinan Changlong Bio-pharmacy Co 3-Year RORE % Calculation

Jilin Province Huinan Changlong Bio-pharmacy Co's 3-Year RORE % for the quarter that ended in Dec. 2025 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 0.043-0.034 )/( 0.12-0 )
=0.009/0.12
=7.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 7.50 mean?
Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) has a 3-Year RORE % of 7.50 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors. According to the industry distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #387 out of 934 companies in the Drug Manufacturers industry, placing it in the top 41.4%.
Is Jilin Province Huinan Changlong Bio-pharmacy Co's 3-Year RORE % too high?
Jilin Province Huinan Changlong Bio-pharmacy Co's current 3-Year RORE % is 7.50. The Drug Manufacturers industry median 3-Year RORE % is 3.09. Jilin Province Huinan Changlong Bio-pharmacy Co's value of 7.50 is 142.7% above this industry median. Based on the distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #387 out of 934 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Jilin Province Huinan Changlong Bio-pharmacy Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Jilin Province Huinan Changlong Bio-pharmacy Co's 3-Year RORE % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #387 out of 934 companies for 3-Year RORE %. This puts Jilin Province Huinan Changlong Bio-pharmacy Co in the upper half of its industry. The industry median 3-Year RORE % is 3.09. Jilin Province Huinan Changlong Bio-pharmacy Co's value of 7.50 is 142.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Drug Manufacturers company?
The median 3-Year RORE % among Drug Manufacturers companies is 3.09, based on 934 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jilin Province Huinan Changlong Bio-pharmacy Co's current 3-Year RORE % of 7.50 is 142.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors. For the Drug Manufacturers industry, the median 3-Year RORE % is 3.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jilin Province Huinan Changlong Bio-pharmacy Co's current 3-Year RORE % is 7.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jilin Province Huinan Changlong Bio-pharmacy Co stock overvalued right now?
Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) has a current 3-Year RORE % of 7.50. The stock's GF Value™ is €0.18, compared to a current price of €0.25 — trading 37.8% above its estimated fair value. The current 3-Year RORE % is 7.50 and 142.7% above the Drug Manufacturers industry median of 3.09. Jilin Province Huinan Changlong Bio-pharmacy Co's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL), the current 3-Year RORE % is 7.50 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) Overvalued in 2026?

Based on GuruFocus' analysis, Jilin Province Huinan Changlong Bio-pharmacy Co stock appears to be overvalued. The current stock price of €0.25 is trading 37.8% above its estimated GF Value™ of €0.18.

Key valuation signals for STU:JIL:

  • 3-Year RORE %: 7.50
  • GF Value™: €0.18 vs. price of €0.25 (37.8% above fair value)
  • GF Score™: 81/100 with 1 warning sign
  • Industry Position: 142.7% above the Drug Manufacturers median (#387 of 934)

No single metric tells the full story. See the STU:JIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jilin Province Huinan Changlong Bio-pharmacy Co Business Description

Other Exchanges 08049:Hong KongJIL:Germany
Address 625 & 639 Nathan Road, Room 1101-2, 11th Floor, Office Tower Two, Grand Plaza, Mong kok, Kowloon, Hong Kong, HKG
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products in the PRC under the brand names of Changlong and Qing Tong. The company has only one business segment. It generates revenue from the Sales of Chinese medicines and pharmaceutical products. Geographically, it derives its entire revenue from the PRC.
81GF Score

Get the complete analysis for STU:JIL

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.25
Price
€0.18
GF Value